ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

HRMY Harmony Biosciences Holdings Inc

31.69
1.42 (4.69%)
2024年5月3日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Harmony Biosciences Holdings Inc HRMY NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.42 4.69% 31.69 08:51:22
始値 安値 高値 終値 前日終値
30.92 30.34 31.82 31.69 30.27
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/3020:05GLOBEHarmony Biosciences Reports Strong First Quarter Financial..
2024/4/3020:00PRNUSHarmony Biosciences Acquires Epygenix Therapeutics, Inc.,..
2024/4/1621:05PRNUSHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL..
2024/4/1121:05PRNUSHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP..
2024/4/0321:05PRNUSHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL..
2024/3/2621:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM..
2024/3/1206:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0906:21EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2907:16EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2024/2/2822:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR..
2024/2/2306:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2222:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2221:45EDGAR2Form 8-K - Current report
2024/2/2221:30GLOBEHarmony Biosciences Reports Fourth Quarter and Full Year..
2024/2/2122:05PRNUSU.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO..
2024/2/2022:05PRNUSHARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG..
2024/2/1409:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:05PRNUSHARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR..
2024/1/2706:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/2706:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2706:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0822:30EDGAR2Form 8-K - Current report
2024/1/0822:05PRNUSHARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND..
2024/1/0322:05PRNUSHARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P...
2023/12/0806:06EDGAR2Form 8-K/A - Current report: [Amend]
2023/12/0722:05PRNUSHARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM..
2023/12/0522:05PRNUSHARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY..
2023/11/1622:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th..
2023/11/1522:05PRNUSHARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING..
2023/11/0906:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0823:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0822:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/0822:30EDGAR2Form 8-K - Current report
2023/11/0822:05PRNUSHARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD..
2023/10/3121:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/3120:45EDGAR2Form 8-K - Current report
2023/10/3120:30GLOBEHarmony Biosciences Reports Strong Third Quarter 2023..
2023/10/2621:05PRNUSHARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE..
2023/10/1721:05PRNUSHARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL..
2023/10/1321:15EDGAR2Form 8-K - Current report
2023/10/1321:00PRNUSHARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3..
2023/10/1121:15EDGAR2Form 8-K - Current report
2023/10/1121:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
2023/10/0605:15EDGAR2Form 8-K - Current report
2023/10/0521:05PRNUSHARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM..
2023/10/0421:00EDGAR2Form 8-K - Current report
2023/9/2721:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
2023/9/2521:00EDGAR2Form 8-K - Current report
2023/9/2021:05PRNUSHARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D.,..

最近閲覧した銘柄

Delayed Upgrade Clock